Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors
Open Access
- 21 October 2009
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 7 (11), 1809-1815
- https://doi.org/10.1111/j.1538-7836.2009.03615.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?Haemophilia, 2008
- Back to the future: a recent history of haemophilia treatmentHaemophilia, 2008
- Inhibitor DevelopmentHaemophilia, 2008
- European Study on Orthopaedic Status of haemophilia patients with inhibitorsHaemophilia, 2007
- International workshop on immune tolerance induction: consensus recommendations1Haemophilia, 2007
- An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agentsHaemophilia, 2006
- Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitorsHaemophilia, 2006
- The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99Journal of Thrombosis and Haemostasis, 2004
- Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study GroupBlood, 2003
- The epidemiology of inhibitors in haemophilia A: a systematic reviewHaemophilia, 2003